GP0381D ALL patients in US

Global Patients is collaborating on a research study to better understand and assess the experience of patients with acute lymphoblastic leukemia (ALL). The research study is being conducted with IQVIATM, a healthcare research firm (, and a pharmaceutical company that is working on developing therapies for patients with ALL.

We are seeking patients with ALL who:

  • are age 55 and older
  • are age 40-55 who have comorbidities that make them ineligible for high intensity chemotherapy

The research will involve participating in either one 90 minute telephone interview or two 45minute interviews. In appreciation of your time, we are offering an electronic gift card for $150 after the interview is completed.

The interview will explore your symptoms of ALL and how they have impacted your life. It will also explore your thoughts about questionnaires that may be used for future ALL clinical trials. This research may help inform how the symptoms and impacts of ALL, which affect patient quality of life, are measured in upcoming clinical trials.

The study is strictly for research purposes; there will be absolutely no sales nor promotional activities.

Prior to the interview, IQVIA will ask you to obtain confirmation of your ALL diagnosis from your physician or staff at your physician’s office and confirm your eligibility for this study.

If you are interested in study participation, or have any questions, please contact us at

Join this Study
Are you already a member of Global Patients?